GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4- yl)-2-(pyridin-4-yl)-5H-PYRROLO[2,3-B]PYRAZINE

Analyse Crystal structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QPA
Type
protein
Length
678 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P28482
Ligands
35W
Pockets
12 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33236% helix, 14% strandP28482
BMitogen-activated protein kinase 1 (EC 2.7.11.24)protein34638% helix, 13% strandP28482

Ligands and binding sites

  • 35W · 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19840.750.788535W
23850.750.8542empty
33620.670.813535W
43240.590.7739empty
5780.450.8117empty

Interfaces

1 interface between chains.

  • A–B · 931 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 4QPA · Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.